Alios BioPharma Raises $8.4 Million
Alios BioPharma Inc., a South San Francisco-based drug startup, has raised $8.4 million in Series A funding, according to a regulatory filing. Backers include Novo AS, Novartis BioVentures and Roche Finance Ltd. The company says that it plans to “treat diseases in virology by activating pathways in the innate immune system.” www.aliosbiopharma.com
9 February 2009•1 min read
